Collection: LDLa
Description: | Low-density lipoprotein receptor domain class A |
---|---|
Total number of clones in the collection: | 100 |
Price: | $ 700.0 ($7.00 per clone) |
Use Restriction: | No restriction |
To request individual clones from the collection, view the list and click "add to cart" (far right-hand side of the table) to add individual clones to your cart.
List of clones:
Explanation of Terms |
Clone ID | Clone Type |
Gene Symbol |
Gene Name |
Reference Sequence |
Mutation/ Discrepancy |
Insert Format |
Vector | |
---|---|---|---|---|---|---|---|---|
HsCD00001754 | cDNA | SPINT1 | serine protease inhibitor, Kunitz type 1 | BC004140 | No/No | FUSION | pDNR-Dual | |
HsCD00001755 | cDNA | SPINT1 | serine protease inhibitor, Kunitz type 1 | BC004140 | No/No | CLOSED | pDNR-Dual | |
HsCD00001756 | cDNA | SPINT1 | serine protease inhibitor, Kunitz type 1 | BC004140 | No/No | CLOSED | pDNR-Dual | |
HsCD00003655 | cDNA | LRP3 | low density lipoprotein receptor-related protein 3 | BC007408 | No/No | FUSION | pDNR-Dual | |
HsCD00004643 | cDNA | LDLR | low density lipoprotein receptor (familial hypercholesterolemia) | BC014514 | No/No | FUSION | pDNR-Dual | |
HsCD00004644 | cDNA | LDLR | low density lipoprotein receptor (familial hypercholesterolemia) | BC014514 | No/No | CLOSED | pDNR-Dual | |
HsCD00005650 | cDNA | ST14 | suppression of tumorigenicity 14 (colon carcinoma, matriptase, epithin) | BC030532 | No/No | FUSION | pDNR-Dual | |
HsCD00039565 | cDNA | LDLR | low density lipoprotein receptor (familial hypercholesterolemia) | BC014514 | No/No | FUSION | pDONR221 | |
HsCD00039846 | cDNA | DGCR2 | DiGeorge syndrome critical region gene 2 | BC032430 | No/Yes | FUSION | pDONR221 | |
HsCD00040128 | cDNA | ST14 | suppression of tumorigenicity 14 (colon carcinoma, matriptase, epithin) | BC030532 | No/No | FUSION | pDONR221 | |
HsCD00040129 | cDNA | C6 | complement component 6 | BC035723 | No/No | FUSION | pDONR221 | |
HsCD00041243 | cDNA | SPINT1 | serine protease inhibitor, Kunitz type 1 | BC004140 | No/No | FUSION | pDONR221 | |
HsCD00041275 | cDNA | LRP12 | low density lipoprotein-related protein 12 | BC032109 | No/No | FUSION | pDONR221 | |
HsCD00042764 | cDNA | SPINT1 | serine peptidase inhibitor, Kunitz type 1 | BC018702 | No/No | CLOSED | pDONR221 | |
HsCD00043274 | cDNA | C6 | complement component 6 | BC035723 | No/No | FUSION | pDONR221 | |
HsCD00043427 | cDNA | C9 | complement component 9 | BC020721 | No/No | CLOSED | pDONR221 | |
HsCD00043709 | cDNA | ST14 | suppression of tumorigenicity 14 (colon carcinoma, matriptase, epithin) | BC030532 | No/No | CLOSED | pDONR221 | |
HsCD00044356 | cDNA | SPINT1 | serine protease inhibitor, Kunitz type 1 | BC004140 | No/No | FUSION | pDONR221 | |
HsCD00044386 | cDNA | LRP12 | low density lipoprotein-related protein 12 | BC032109 | No/No | FUSION | pDONR221 | |
HsCD00073579 | cDNA | TMPRSS6 | transmembrane protease, serine 6 | CR456446 | No/No | FUSION | pENTR223 | |
HsCD00073673 | cDNA | TMPRSS6 | transmembrane protease, serine 6 | CR456446 | No/No | CLOSED | pENTR223 | |
HsCD00073980 | cDNA | DGCR2 | DiGeorge syndrome critical region gene 2 | CR456433 | No/No | FUSION | pENTR223 | |
HsCD00074075 | cDNA | DGCR2 | DiGeorge syndrome critical region gene 2 | CR456433 | No/No | CLOSED | pENTR223 | |
HsCD00074203 | cDNA | SPINT1 | serine protease inhibitor, Kunitz type 1 | BC004140 | No/No | CLOSED | pJP1520 | |
HsCD00074209 | cDNA | LDLR | low density lipoprotein receptor (familial hypercholesterolemia) | BC014514 | No/No | CLOSED | pJP1520 | |
HsCD00074264 | cDNA | SPINT1 | serine protease inhibitor, Kunitz type 1 | BC004140 | No/No | CLOSED | pJP1520 | |
HsCD00076250 | cDNA | LRP3 | low density lipoprotein receptor-related protein 3 | BC007408 | No/No | FUSION | pDONR221 | |
HsCD00076802 | cDNA | LDLR | low density lipoprotein receptor (familial hypercholesterolemia) | BC014514 | No/No | FUSION | pANT7_cGST | |
HsCD00077303 | cDNA | C6 | complement component 6 | BC035723 | No/No | FUSION | pANT7_cGST | |
HsCD00077652 | cDNA | DGCR2 | DiGeorge syndrome critical region gene 2 | BC032430 | No/Yes | FUSION | pANT7_cGST | |
HsCD00078125 | cDNA | SPINT1 | serine protease inhibitor, Kunitz type 1 | BC004140 | No/No | FUSION | pANT7_cGST | |
HsCD00079531 | cDNA | ALK | anaplastic lymphoma kinase (Ki-1) | NM_004304 | No/Yes | CLOSED | pDNR-Dual | |
HsCD00080346 | cDNA | LGR8 | leucine-rich repeat-containing G protein-coupled receptor 8 | NM_130806 | No/No | FUSION | pENTR223.1 | |
HsCD00080406 | cDNA | TMPRSS9 | transmembrane protease, serine 9 | NM_182973 | No/No | FUSION | pENTR223.1 | |
MmCD00080975 | cDNA | Mfrp | membrane-type frizzled-related protein | NM_147126 | No/No | FUSION | pENTR223.1 | |
HsCD00082842 | cDNA | ALK | anaplastic lymphoma kinase (Ki-1) | NM_004304 | No/No | FUSION | pENTR223.1 | |
HsCD00082914 | cDNA | LGR8 | leucine-rich repeat-containing G protein-coupled receptor 8 | NM_130806 | No/No | CLOSED | pENTR223.1 | |
MmCD00083430 | cDNA | Mfrp | membrane-type frizzled-related protein | NM_147126 | No/No | CLOSED | pENTR223.1 | |
HsCD00287996 | cDNA | C18orf1 | chromosome 18 open reading frame 1 | BC030199.1 | No/No | FUSION | pENTR223 | |
HsCD00288448 | cDNA | TMPRSS4 | transmembrane protease, serine 4 | BC011703.2 | No/No | FUSION | pENTR223 | |
HsCD00289198 | cDNA | TMPRSS2 | transmembrane protease, serine 2 | BC051839.1 | No/No | FUSION | pENTR223 | |
MmCD00294861 | cDNA | Tmprss9 | NA | NM_001081688.1 | No/No | CLOSED | pENTR223.1 | |
HsCD00295552 | cDNA | MFRP | membrane frizzled-related protein | NM_031433.1 | No/No | FUSION | pENTR223.1 | |
HsCD00295925 | cDNA | CD320 | CD320 molecule | AL136652.1 | No/No | FUSION | pDONR221 | |
HsCD00297080 | cDNA | NETO2 | neuropilin (NRP) and tolloid (TLL)-like 2 | NM_018092.3 | No/No | FUSION | pENTR223.1 | |
HsCD00301258 | cDNA | TMPRSS6 | transmembrane protease, serine 6 | CR456446 | No/No | FUSION | pANT7_cGST | |
HsCD00304002 | cDNA | TMPRSS4 | transmembrane protease, serine 4 | BC011703.2 | No/No | FUSION | pANT7_cGST | |
HsCD00350625 | cDNA | ALK | anaplastic lymphoma receptor tyrosine kinase | BC156207 | No/No | FUSION | pENTR223.1 | |
HsCD00350891 | cDNA | DGCR2 | DiGeorge syndrome critical region gene 2 | CU012993 | No/No | FUSION | pENTR223 | |
HsCD00350912 | cDNA | TMPRSS6 | transmembrane protease, serine 6 | CU013332 | No/No | FUSION | pENTR223 | |
HsCD00351008 | cDNA | TMPRSS6 | transmembrane protease, serine 6 | CU013044 | No/No | CLOSED | pENTR223 | |
HsCD00351275 | cDNA | DGCR2 | DiGeorge syndrome critical region gene 2 | CU013281 | No/No | FUSION | pENTR223 | |
HsCD00353153 | cDNA | C18orf1 | chromosome 18 open reading frame 1 | HQ447439 | No/No | FUSION | pDONR223 | |
HsCD00353745 | cDNA | TMPRSS7 | transmembrane protease, serine 7 | HQ258472 | No/No | FUSION | pDONR223 | |
HsCD00353747 | cDNA | RXFP1 | relaxin/insulin-like family peptide receptor 1 | HQ258496 | No/No | FUSION | pDONR223 | |
HsCD00353776 | cDNA | C8B | complement component 8, beta polypeptide | HQ258464 | No/No | FUSION | pDONR223 | |
HsCD00356927 | cDNA | C18orf1 | chromosome 18 open reading frame 1 | HQ447439 | No/No | FUSION | pANT7_cGST | |
HsCD00398456 | cDNA | C8A | complement component 8, alpha polypeptide | HQ258328 | No/No | FUSION | pDONR223 | |
HsCD00399078 | cDNA | MAMDC4 | MAM domain containing 4 | BC172486 | No/No | CLOSED | pENTR223.1 | |
HsCD00402650 | cDNA | DGCR2 | DiGeorge syndrome critical region gene 2 | CU013281 | No/No | FUSION | pANT7_cGST | |
HsCD00402667 | cDNA | TMPRSS6 | transmembrane protease, serine 6 | CU013332 | No/No | FUSION | pANT7_cGST | |
HsCD00402988 | cDNA | ALK | anaplastic lymphoma receptor tyrosine kinase | BC156207 | No/No | FUSION | pANT7_cGST | |
HsCD00403485 | cDNA | TMPRSS7 | transmembrane protease, serine 7 | HQ258472 | No/No | FUSION | pANT7_cGST | |
HsCD00403487 | cDNA | RXFP1 | relaxin/insulin-like family peptide receptor 1 | HQ258496 | No/No | FUSION | pANT7_cGST | |
HsCD00403514 | cDNA | C8B | complement component 8, beta polypeptide | HQ258464 | No/No | FUSION | pANT7_cGST | |
HsCD00404001 | cDNA | C8A | complement component 8, alpha polypeptide | HQ258328 | No/No | FUSION | pANT7_cGST | |
HsCD00434290 | cDNA | C6 | complement component 6 | DQ894443 | No/No | FUSION | pLX304 | |
HsCD00435265 | cDNA | SPINT1 | serine peptidase inhibitor, Kunitz type 1 | DQ895493 | No/No | FUSION | pLX304 | |
HsCD00435393 | cDNA | DGCR2 | DiGeorge syndrome critical region gene 2 | DQ894160 | No/No | FUSION | pLX304 | |
HsCD00435929 | cDNA | TMPRSS2 | transmembrane protease, serine 2 | HQ448630 | No/No | FUSION | pLX304 | |
HsCD00436382 | cDNA | ST14 | suppression of tumorigenicity 14 (colon carcinoma) | DQ894442 | No/No | FUSION | pLX304 | |
HsCD00436638 | cDNA | RXFP1 | relaxin/insulin-like family peptide receptor 1 | HQ258496 | No/No | FUSION | pLX304 | |
HsCD00437100 | cDNA | LDLRAD1 | low density lipoprotein receptor class A domain containing 1 | No/No | FUSION | pLX304 | ||
HsCD00438240 | cDNA | TMPRSS4 | transmembrane protease, serine 4 | No/Yes | FUSION | pLX304 | ||
HsCD00439551 | cDNA | C18orf1 | chromosome 18 open reading frame 1 | HQ447439 | No/No | FUSION | pLX304 | |
HsCD00439711 | cDNA | C7 | complement component 7 | HQ258008 | No/No | FUSION | pLX304 | |
HsCD00439730 | cDNA | LRP1 | low density lipoprotein receptor-related protein 1 | No/No | FUSION | pLX304 | ||
HsCD00442800 | cDNA | CFI | complement factor I | No/No | FUSION | pLX304 | ||
HsCD00442869 | cDNA | C9 | complement component 9 | DQ891410 | No/No | FUSION | pLX304 | |
HsCD00443012 | cDNA | CD320 | CD320 molecule | EU831651 | No/No | FUSION | pLX304 | |
HsCD00446558 | cDNA | C8B | complement component 8, beta polypeptide | HQ258464 | No/No | FUSION | pLX304 | |
HsCD00446567 | cDNA | C8A | complement component 8, alpha polypeptide | HQ258328 | No/No | FUSION | pLX304 | |
HsCD00446579 | cDNA | TMPRSS7 | transmembrane protease, serine 7 | No/No | FUSION | pLX304 | ||
HsCD00505625 | cDNA | RXFP1 | relaxin/insulin-like family peptide receptor 1 | HQ258496 | No/No | FUSION | pENTR223 | |
HsCD00505812 | cDNA | C7 | complement component 7 | HQ258008 | No/No | FUSION | pENTR223 | |
HsCD00505887 | cDNA | C6 | complement component 6 | DQ894443 | No/No | FUSION | pENTR223 | |
HsCD00507283 | cDNA | LDLRAD1 | low density lipoprotein receptor class A domain containing 1 | No/No | FUSION | pENTR223 | ||
HsCD00510522 | cDNA | C18orf1 | chromosome 18 open reading frame 1 | HQ447439 | No/No | FUSION | pENTR223 | |
HsCD00511751 | cDNA | CFI | complement factor I | No/No | FUSION | pENTR223 | ||
HsCD00512508 | cDNA | C9 | complement component 9 | DQ891410 | No/No | FUSION | pENTR223 | |
HsCD00512545 | cDNA | ST14 | suppression of tumorigenicity 14 (colon carcinoma) | DQ894442 | No/No | FUSION | pENTR223 | |
HsCD00512701 | cDNA | CD320 | CD320 molecule | EU831651 | No/No | CLOSED | pENTR223 | |
HsCD00513029 | cDNA | SPINT1 | serine peptidase inhibitor, Kunitz type 1 | DQ895493 | No/No | FUSION | pENTR223 | |
HsCD00513306 | cDNA | DGCR2 | DiGeorge syndrome critical region gene 2 | DQ894160 | No/No | FUSION | pENTR223 | |
HsCD00513473 | cDNA | TMPRSS7 | transmembrane protease, serine 7 | No/No | FUSION | pENTR223 | ||
HsCD00513570 | cDNA | C8B | complement component 8, beta polypeptide | HQ258464 | No/No | FUSION | pENTR223 | |
HsCD00513576 | cDNA | C8A | complement component 8, alpha polypeptide | HQ258328 | No/No | FUSION | pENTR223 | |
HsCD00513790 | cDNA | TMPRSS2 | transmembrane protease, serine 2 | HQ448630 | No/No | FUSION | pENTR223 | |
HsCD00515702 | cDNA | TMPRSS3 | transmembrane protease, serine 3 | No/No | FUSION | pENTR223 | ||
HsCD00516355 | cDNA | VLDLR | very low density lipoprotein receptor | No/No | FUSION | pENTR223 |